0 CHECKOUT

Cancer Pain - Pipeline Review, H1 2015

  • ID: 3334699
  • June 2015
  • 137 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Aphios Corporation
  • Benitec Biopharma Limited
  • GW Pharmaceuticals Plc
  • Kolon Life Science, Inc.
  • Nippon Kayaku Co., Ltd.
  • MORE

Cancer Pain - Pipeline Review, H1 2015

Summary

This, ‘Cancer Pain - Pipeline Review, H1 2015’, provides an overview of the Cancer Pain’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Cancer Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cancer Pain and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Aphios Corporation
  • Benitec Biopharma Limited
  • GW Pharmaceuticals Plc
  • Kolon Life Science, Inc.
  • Nippon Kayaku Co., Ltd.
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Cancer Pain Overview
Therapeutics Development
Pipeline Products for Cancer Pain - Overview
Pipeline Products for Cancer Pain - Comparative Analysis
Cancer Pain - Therapeutics under Development by Companies
Cancer Pain - Therapeutics under Investigation by Universities/Institutes
Cancer Pain - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Cancer Pain - Products under Development by Companies
Cancer Pain - Products under Investigation by Universities/Institutes
Cancer Pain - Companies Involved in Therapeutics Development
Amgen Inc.
Amorsa Therapeutics Inc.
AngioChem Inc.
Aphios Corporation
AstraZeneca Plc
BCN Peptides, S.A.
Benitec Biopharma Limited
BioDelivery Sciences International, Inc.
ChironWells GmbH
Daiichi Sankyo Company, Limited
Grunenthal GmbH
GW Pharmaceuticals Plc
Immupharma Plc
IntelGenx Corp.
Kolon Life Science, Inc.
Nektar Therapeutics
Neurocentrx Pharma Ltd.
Nippon Kayaku Co., Ltd.
Northern Light Pharmaceuticals AB
Orion Oyj
Pain Therapeutics, Inc.
Pfizer Inc.
Pharmaleads
Recordati S.p.A.
Sorrento Therapeutics, Inc.
Virobay Inc.
Winston Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc.
Cancer Pain - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AMS-410 ER12 - Drug Profile
ANG-2002 - Drug Profile
BBI-11008 - Drug Profile
calpastatin - Drug Profile
cebranopadol - Drug Profile
crotalphine - Drug Profile
DD-04107 - Drug Profile
dexmedetomidine hydrochloride - Drug Profile
dronabinol - Drug Profile
Drug for Cancer Neuropathic Pain - Drug Profile
fentanyl - Drug Profile
fentanyl citrate - Drug Profile
fentanyl citrate - Drug Profile
fulranumab - Drug Profile
HS-198 - Drug Profile
hydromorphone hydrochloride - Drug Profile
INT-0028 - Drug Profile
IPP-102199 - Drug Profile
ketamine hydrochloride ER - Drug Profile
KLS-2010 - Drug Profile
methadone hydrochloride - Drug Profile
nabiximols - Drug Profile
Nervarna - Drug Profile
NKTR-192 - Drug Profile
Peptide to Block Voltage-Dependent N-Type Calcium Channel for Cancer Pain and Fibromyalgia - Drug Profile
PGN-202 - Drug Profile
PL-265 - Drug Profile
Q-201 - Drug Profile
QX-314 - Drug Profile
resiniferatoxin - Drug Profile
saracatinib difumarate - Drug Profile
Small Molecule 1 to Block Sodium Channels for Cancer Pain and Epilepsy - Drug Profile
Small Molecule 2 to Block Sodium Channels for Cancer Pain and Epilepsy - Drug Profile
Small Molecule 3 to Block Sodium Channels for Cancer Pain and Epilepsy - Drug Profile
Small Molecule to Antagonize Chemokine Receptor for Cancer Pain - Drug Profile
tanezumab - Drug Profile
VBY-825 - Drug Profile
zucapsaicin - Drug Profile
ZYN-001 - Drug Profile
Cancer Pain - Recent Pipeline Updates
Cancer Pain - Dormant Projects
Cancer Pain - Discontinued Products
Cancer Pain - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Cancer Pain, H1 2015
Number of Products under Development for Cancer Pain - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Investigation by Universities/Institutes, H1 2015
Cancer Pain - Pipeline by Amgen Inc., H1 2015
Cancer Pain - Pipeline by Amorsa Therapeutics Inc., H1 2015
Cancer Pain - Pipeline by AngioChem Inc., H1 2015
Cancer Pain - Pipeline by Aphios Corporation, H1 2015
Cancer Pain - Pipeline by AstraZeneca Plc, H1 2015
Cancer Pain - Pipeline by BCN Peptides, S.A., H1 2015
Cancer Pain - Pipeline by Benitec Biopharma Limited, H1 2015
Cancer Pain - Pipeline by BioDelivery Sciences International, Inc., H1 2015
Cancer Pain - Pipeline by ChironWells GmbH, H1 2015
Cancer Pain - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Cancer Pain - Pipeline by Grunenthal GmbH, H1 2015
Cancer Pain - Pipeline by GW Pharmaceuticals Plc, H1 2015
Cancer Pain - Pipeline by Immupharma Plc, H1 2015
Cancer Pain - Pipeline by IntelGenx Corp., H1 2015
Cancer Pain - Pipeline by Kolon Life Science, Inc., H1 2015
Cancer Pain - Pipeline by Nektar Therapeutics, H1 2015
Cancer Pain - Pipeline by Neurocentrx Pharma Ltd., H1 2015
Cancer Pain - Pipeline by Nippon Kayaku Co., Ltd., H1 2015
Cancer Pain - Pipeline by Northern Light Pharmaceuticals AB, H1 2015
Cancer Pain - Pipeline by Orion Oyj, H1 2015
Cancer Pain - Pipeline by Pain Therapeutics, Inc., H1 2015
Cancer Pain - Pipeline by Pfizer Inc., H1 2015
Cancer Pain - Pipeline by Pharmaleads , H1 2015
Cancer Pain - Pipeline by Recordati S.p.A., H1 2015
Cancer Pain - Pipeline by Sorrento Therapeutics, Inc., H1 2015
Cancer Pain - Pipeline by Virobay Inc., H1 2015
Cancer Pain - Pipeline by Winston Pharmaceuticals, Inc., H1 2015
Cancer Pain - Pipeline by Zynerba Pharmaceuticals, Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Cancer Pain Therapeutics - Recent Pipeline Updates, H1 2015
Cancer Pain - Dormant Projects, H1 2015
Cancer Pain - Dormant Projects (Contd..1), H1 2015
Cancer Pain - Dormant Projects (Contd..2), H1 2015
Cancer Pain - Dormant Projects (Contd..3), H1 2015
Cancer Pain - Discontinued Products, H1 2015
Cancer Pain - Discontinued Products (Contd..1), H1 2015

List of Figures
Number of Products under Development for Cancer Pain, H1 2015
Number of Products under Development for Cancer Pain - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Amgen Inc.
Amorsa Therapeutics Inc.
AngioChem Inc.
Aphios Corporation
AstraZeneca Plc
BCN Peptides, S.A.
Benitec Biopharma Limited
BioDelivery Sciences International, Inc.
ChironWells GmbH
Daiichi Sankyo Company, Limited
Grunenthal GmbH
GW Pharmaceuticals Plc
Immupharma Plc
IntelGenx Corp.
Kolon Life Science, Inc.
Nektar Therapeutics
Neurocentrx Pharma Ltd.
Nippon Kayaku Co., Ltd.
Northern Light Pharmaceuticals AB
Orion Oyj
Pain Therapeutics, Inc.
Pfizer Inc.
Pharmaleads
Recordati S.p.A.
Sorrento Therapeutics, Inc.
Virobay Inc.
Winston Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Baxter International Inc.
  • Endo International Plc.
  • Medtronic, Inc.
  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Purdue Pharma L.P.